A combination of four different herbal extracts may significantly reduce hot flashes and sweating, improve sleep, and boost mood in post-menopausal women, says a new study.
There is “insufficient” evidence to show that soy isoflavones can benefit bone health and ease menopausal conditions, according to the European Union’s central science agency.
Oral supplementation with soy isoflavones could help to make radiation treatment of lung cancer tumours more effective while helping to preserve normal tissue, according to new research.
Concerns over the potential increase in the risk of breast cancer recurrence from consuming soy isoflavones may be unfounded, according to combined data from over 16,000 women.
The manner in which pre-menstrual and menopausal indications for soy and red clover isoflavones that recently won approval from the European Patent Office can be translated into marketing messages, is being debated among soy players.
Soy isoflavones do not increase or decrease the density of breasts, say results of a new clinical trial from the US that support the safety of the supplements.
A soy isoflavone used in soy infant formula could reduce diarrhea
in infants, according to a new study, and thereby save lives in
developing countries.
The potential cardiovascular benefits of soy isoflavones may also
include reducing the early stage of artery hardening, if the
results of an animal study can be translated into humans.
Isoflavones in the their aglycone form are absorbed faster and in
bigger amounts from soy milk than the glucoside form, reports a new
study from Yakult.
The body's ability to absorb and benefit from soy isoflavones is
greater when taken from juice but not cookies, results that have
implications for using soy isoflavones as functional ingredients.
Isoflavones from soy do not increase markers for breast cancer in
postmenopausal women and could protect against the disease,
suggests a new animal study.
Archer Daniels Midland said yesterday that it has acquired Solae's
global soy isoflavone business, including its entire portfolio of
US and foreign patents.
A long-term soy diet may not pose an increased risk of breast or
womb cancer among postmenopausal women, as some people have feared,
suggests new research carried out on monkeys.
Preliminary research in the US finds that soy isoflavones, found in
soy infant formula, do not disrupt infant development, despite
concerns from some scientists that the isoflavones could act like
female hormones in infants.